Florida closes all monoclonal antibody treatment sites due to FDA decision

All monoclonal antibody treatment sites in Florida closed until further notice due to FDA decision Florida is closing its monoclonal antibody treatment sites, health officials announced late Monday, citing the US Food and Drug Administration's decision to limit the use of certain versions of the treatments that were found less effective against the now-dominant Omicron variant of coronavirus. By <a href="/profiles/aditi-sandal">Aditi Sangal</a> and <a href="/profiles/adrienne-vogt">Adrienne Vogt</a>, CNN CNN

...

"Unfortunately, as a result of this abrupt decision made by the federal government, all monoclonal antibody state sites will be closed until further notice," the Florida Department of Health said in a statement.

More than 2,000 appointments for the treatment were canceled in the state on Tuesday alone, according to a statement from Gov. Ron DeSantis.

Earlier Monday, the FDA said it was revising the authorizations for monoclonal antibody treatments made by Eli Lilly (bamlanivimab and etesevimab, administered together) and Regeneron (REGEN-COV, or casirivimab and imdevimab), because data showed they are "highly unlikely to be active against the omicron variant." ...